1. Home
  2. TWIN vs TVGN Comparison

TWIN vs TVGN Comparison

Compare TWIN & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

N/A

Current Price

$24.98

Market Cap

367.7M

Sector

Industrials

ML Signal

N/A

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

N/A

Current Price

$6.00

Market Cap

21.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TWIN
TVGN
Founded
1918
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Blank Checks
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
367.7M
21.3M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
TWIN
TVGN
Price
$24.98
$6.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 55.1K
7.0K
Earning Date
11-04-2026
11-24-2026
Dividend Yield
★ 0.83%
N/A
EPS Growth
★ 1428.57
N/A
EPS
★ 0.24
N/A
Revenue
★ $381,270,000.00
N/A
Revenue This Year
$7.56
N/A
Revenue Next Year
$8.00
N/A
P/E Ratio
$101.54
★ N/A
Revenue Growth
★ 11.90
N/A
52 Week Low
$14.22
$0.14
52 Week High
$29.24
$24.91

Technical Indicators

Market Signals
Indicator
TWIN
TVGN
Relative Strength Index (RSI) 50.50 46.06
Support Level $22.10 $4.14
Resistance Level $27.58 $7.33
Average True Range (ATR) 1.37 0.45
MACD -0.02 -0.01
Stochastic Oscillator 50.19 49.75

Price Performance

Historical Comparison
TWIN
TVGN

About TWIN Twin Disc Incorporated

Twin Disc Inc designs, manufactures and sells marine and heavy-duty off highway power transmission equipment. Its products are marine transmissions, azimuth drives, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, controls systems, and braking systems. The company sells its products to customers in the pleasure craft, commercial, and military marine markets, as well as in the energy and natural resources, government, military, and industrial markets. It has two reportable segments: manufacturing and distribution. It derives the maximum revenue from the manufacturing segment. Geographically, it operates in United States, Netherlands, Finland, China, Australia, Italy and Others.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: